Locations Investor Relations IMPACT Online LOGIN REGISTER Products Solutions Learning Center About Haemonetics Customer Support Home About Haemonetics Company Background Leadership Team Contact Us Leadership Team BRIAN CONCANNON President & CEO Brian Concannon joined Haemonetics in 2003 as President of the Patient Division. He was promoted to President of Global Markets in 2006 and then to Chief Operating Officer in 2007. In April 2009, he was promoted to President and Chief Executive Officer, and elected to the Haemonetics Board of Directors. Immediately prior to joining Haemonetics, Mr. Concannon was President of the Northeast Region at Cardinal Health Medical Products and Services where he was employed since 1998. From 1985 to 1998, he was employed by American Hospital Supply Corporation, Baxter Healthcare Corporation, and Allegiance Healthcare in a series of sales and operations management positions of increasing responsibility. PETER ALLEN President, Global Plasma Peter Allen joined Haemonetics in 2003 as President of the Donor Division. In March 2008, Mr. Allen was appointed Chief Marketing Officer. In October 2011, he was promoted to President of Global Plasma. Prior to joining Haemonetics, Mr. Allen was Vice President of The Aethena Group, a private equity firm providing services to the global healthcare industry. From 1998 to 2001, he held various positions including Vice President of Sales and the Oncology Business at Syncor International, a provider of radiopharmaceutical and comprehensive medical imaging services. More BRIAN BURNS EVP, Global Quality and Regulatory Affairs Brian R. Burns joined Haemonetics in January 2014 as Executive Vice President of Global Quality and Regulatory Affairs. In this role, he is responsible for the development and implementation of the global quality and regulatory strategies. Mr. Burns previously held Executive Level roles in Quality and Regulatory for Fresenius Medical Corporation and Boston Scientific along with Operational roles with Cardinal Healthcare, Allegiance Healthcare, and Baxter Healthcare. He received his Bachelor of Science degree in Chemical Engineering from the University of Arkansas. KENT DAVIES President, Global Markets Kent Davies joined Haemonetics in 2014 as President of Global Markets. In this role, he is responsible for worldwide oversight of all of Haemonetics’ commercial operations, excluding the Global Plasma business. Previously, Mr. Davies was the CEO of RoundTable Healthcare Partners' RoundTable III Platform Development Corporation (RPDC) where he focused on the identification and development of new investment opportunities in the medical device market. Prior to RPDC, he held executive roles of increasing responsibility, including CEO of Gaymar Industries, More DAVID HELSEL EVP, Global Manufacturing David Helsel joined Haemonetics as Vice President of Global Manufacturing in March 2012, and is responsible for worldwide oversight of the Company’s manufacturing and supply chain organizations. Mr. Helsel was previously with Covidien, Ltd. for 16 years, where he most recently was Vice President of Operations for the Surgical Solutions global business unit. During his tenure with Covidien, his previous roles included Vice President of Operations for the Medical Supplies segment and Global Director of Operational Excellence – Manufacturing. Mr. Helsel holds a Bachelor of Science degree in Mechanical Engineering from LeTourneau University. SANDRA L. JESSE EVP, Chief Legal Officer Sandra Jesse joined Haemonetics as Vice President, Chief Legal Officer in September 2011, and is responsible for the company’s world-wide Legal, Compliance and Corporate Audit and Controls groups. Ms. Jesse was previously the Executive Vice President and Chief Legal Officer of Blue Cross Blue Shield of Massachusetts, a Partner in the Boston law firm of Choate, Hall and Stewart, and Press Secretary for United States Congressman, Lee Hamilton. She has served on a number of Boards of Directors, including the New England Legal Foundation, Longy School of Music, Boston Harbor Island Alliance and the Landmark School. Ms. Jesse is a former President of the Boston Bar Foundation. CHRISTOPHER LINDOP CFO & EVP Business Development Christopher Lindop joined Haemonetics in January of 2007 as Chief Financial Officer. In 2007, Mr. Lindop assumed responsibility for business development. Prior to joining Haemonetics, he was Chief Financial Officer at Inverness Medical Innovations, a rapidly growing global developer of advanced consumer and professional diagnostic products from 2003 to 2006. Prior to this, Mr. Lindop was a Partner in the Boston offices of Ernst & Young LLP and Arthur Andersen LLP. DR. JONATHAN WHITE Chief Science and Technology Officer Dr. Jonathan White joined Haemonetics in 2008 as Vice President of Research and Development. Dr. White joined Haemonetics from Pfizer where he held a number of roles including Chief Information Officer. He previously worked at McKinsey and Company in New York. Dr. White is a Fellow of the Royal College of Surgery in England. Contact Us Terms of Use Quality Careers Privacy Policy Site Map © 2013 • Haemonetics Corporation • 400 Wood Road • Braintree • MA • 02184 Website Feedback